Wireless Diabetes Implant Controls Blood Sugar Without Insulin

Researchers in Switzerland have developed a wireless diabetes implant that can bring high blood sugar back to normal without a single dose of insulin. The small device was tested in mice with type 2 diabetes, and its developers say it could one day offer a completely different way of treating the disease.

The implant, called ECHO, works by converting excess glucose in the blood into gluconate, a substance the kidneys then clear from the body through urine. Unlike insulin pumps or injections, it delivers no drug at all. Instead, a small electrical current activates a catalyst made of gold nanoclusters decorated with platinum particles, embedded in a porous graphite felt.

FAKTA

• What: ECHO, a wireless electrocatalytic diabetes implant that converts excess blood glucose into gluconate
• Developed by: a research team at ETH Zurich, led by Professor Martin Fussenegger
• Published: in the journal Science on 22 October 2026
• Tested in: mice with type 2 diabetes and obesity
• Result: blood sugar returned to normal within about one hour
• Size: 26 x 14 x 5 millimetres, implanted under the skin and powered wirelessly
• Status: experimental only — no human trials have begun

How the diabetes implant works

The device is designed to sit under the skin and interact with glucose in the fluid surrounding the tissue, rather than in direct contact with circulating blood. It is powered wirelessly from an external transmitter and can be linked to a continuous glucose monitor, so treatment switches on when sugar levels rise and off when they return to normal.

In the laboratory, the team also showed the catalyst working in five litres of glucose solution, roughly the volume of an adult’s blood. That test demonstrates the chemistry at a larger scale, although it says nothing yet about safety in the human body.

What the mouse trials showed

In diabetic mice, a low-power current of 0.75 volts and 10 milliamperes restored elevated blood sugar to the normal range within an hour. Running the device for 60 minutes a day kept glucose under control for at least six weeks, with no episodes of blood sugar falling too low.

The treated mice also lost up to 10 per cent of their body weight and showed improved use of stored fat. A separate sensor-driven test ran automatically for 12 days, adjusting treatment as glucose levels changed.

A long road before patients benefit

Despite the promising results, the researchers stress that the technology is still at an early stage. It has been tested only in animals, and questions about long-term safety, durability and performance in the human body remain unanswered.

The team now plans to develop ECHO into a medical device, with human testing still ahead. If it eventually proves safe and effective, it could give millions of people with diabetes a treatment that manages blood sugar without insulin, injections or daily medication. More technology and health stories are available on Watan News.